Antidepressants
Monoamine Oxidase Inhibitors (maois), Tricyclic Antidepressants (tcas), Selective Serotonin Reuptake Inhibitors (ssris)
Depression in older adults is now being recognized as a severe and widespread health problem. Despite the availability of newer and safer antidepressants, depression is often unrecognized and undertreated in this population. Currently, there are several classes of antidepressants available for treatment of depression. They could be classified as monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and the miscellaneous group.
Additional topics
- Anxiety - Case One: Generalized Anxiety Disorder, Case Two: Agoraphobia, Case Three: Obsessive-compulsive Disorder
- Anti-Aging Research: Ethical and Religious Perspectives - Cautious Ethical Optimism, The Goodness Of Natural Limits, Conclusions
- Antidepressants - Monoamine Oxidase Inhibitors (maois)
- Antidepressants - Tricyclic Antidepressants (tcas)
- Antidepressants - Selective Serotonin Reuptake Inhibitors (ssris)
- Antidepressants - Miscellaneous
- Other Free Encyclopedias